.jpg)
.png)
All
MIAMI, Fla. – (May 18, 2019) -- Clinical lipidology’s best and brightest up-and-comers have been singled out for their exceptional abstracts at the National Lipid Association’s (NLA) 2019 Scientific Sessions, taking place May 16 – 19 in Miami. Five Young Investigator Abstract Award Winners were... more
Dr. Scott Kirkpatrick is SWLA’s 2022 Lipid Scholarship Program recipient, a PGY-5 cardiology fellow at the University of Arizona-Tuscon. As a future general cardiologist with a passion for preventive cardiology, his career mission is to help as many people as he can in the fight against... more
The NLA partners with various medical education providers to offer many free, online educational opportunities to its members. These include programs on how to lower CVD risk, how to manage lipids beyond statins, and much more. These activities are free of charge and can be completed at your own... more
I am very grateful for the opportunity to be President of the Midwest Chapter of the National Lipid Association. During this year, the Midwest Chapter made a commitment to support the activities of both the NLA and the Foundation of the NLA. Because of that commitment, we have chosen topics for the... more
The Heat is On! Foundation Takeover Thursday, May 29 | 7:15 – 8:30pm ET Let the Foundation of the NLA take over Opening Night of the #NLASessions—Miami style. We’re cranking up the energy and setting the tone for an unforgettable weekend with The Heat is On! Foundation Takeover. Join... more
Did you miss our recent webinar, "Clinical Utility of Genetic Testing in the Diagnosis of Familial Hypercholesterolemia?” You can watch online, free of charge, exclusively on Lipid.org. Join Amy C. Sturm, MS, LGC, as she discusses the use of genetic testing in the diagnosis of patients... more
Our healthcare community, and society as a whole, have navigated significant challenges over the last year and a half related to the COVID-19 pandemic. Racial and ethnic differences and disparities as well as social determinants of health have continued to be trending topics in healthcare. The... more
Inclisiran (Leqvio; Novartis) is now the first small interfering RNA (siRNA) therapy to be approved by the FDA to reduce low-density lipoprotein cholesterol (LDL-C). Inclisiran was previously approved in the EU on 9 December 2020 for use in adults with primary hypercholesterolemia (heterozygous... more
In 2014, the Foundation of the National Lipid Association (FNLA), Preventive Cardiovascular Nurses Association (PCNA), and Mended Hearts launched Cholesterol Counts, a program designed to accumulate Internet-based information on how much people know about their cholesterol, how much they care... more
JK is a 35-year-old female nonsmoker who first presented to clinical lipidology care after developing angina while breastfeeding her first child. A subsequent cardiac catheterization revealed 3-vessel disease, ultimately leading to coronary artery bypass grafting (CABG). Her low-density... more